Assembly Biosciences, Inc. Class of Warrant or Right, Outstanding
Assembly Biosciences, Inc. (ASMB) had Class of Warrant or Right, Outstanding of 10.94 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-13
- 2026-06-30: Class of Warrant or Right, Outstanding 10.94M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 10.53M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 10.53M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 10.53M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 10.94M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 10.53M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 10.53M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 10.53M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 814.00K shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 814.00K shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 814.00K shares 10-K · filed 2026-03-19 |
| 2020-12-31 | 2.42M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 2.42M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 2.44M shares 10-Q · filed 2020-08-05 |
| 2020-03-31 | 2.44M shares 10-Q · filed 2020-05-08 |
| 2019-12-31 | 2.44M shares 10-K · filed 2021-02-25 |
| 2018-12-31 | 15.30K shares 10-K · filed 2019-02-28 |
| 2017-12-31 | 15.30K shares 10-K · filed 2019-02-28 |
| 2017-09-30 | 16.91K shares 10-Q · filed 2017-11-01 |
| 2017-06-30 | 16.91K shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 16.91K shares 10-Q · filed 2017-05-08 |
| 2016-09-30 | 16.91K shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 16.91K shares 10-Q · filed 2016-08-09 |
| 2014-03-31 | 756.18K shares 10-Q · filed 2014-05-14 |
| 2013-12-31 | 861.05K shares 10-Q · filed 2014-05-14 |
| 2013-09-30 | 861.05K shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 874.65K shares 10-Q · filed 2013-08-09 |
| 2013-03-31 | 874.65K shares 10-Q · filed 2013-05-10 |
| 2012-12-31 | 874.65K shares 10-K · filed 2014-03-31 |
| 2012-09-30 | 874.65K shares 10-Q · filed 2012-11-13 |
| 2012-06-30 | 910.61K shares 10-Q · filed 2012-08-09 |
| 2011-12-31 | 956.44K shares 10-K · filed 2014-03-31 |
| 2010-12-31 | 1.01M shares 10-K · filed 2013-03-18 |
| 2009-12-31 | 168.88K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |